JCR Pharmaceuticals Co Eulerpool Vijesti

JCR Pharmaceuticals Co Eulerpool News

JCR Pharmaceuticals Co Aktie News

JCR Pharmaceuticals Co prate mnogi novinari i investitori širom svijeta. Najnovije JCR Pharmaceuticals Co vijesti prikupljamo ovdje.

• 5. rujna ·

  Yahoo
  JCR Pharmaceuticals’ Data Presentations at SSIEM Annual Symposium 2024 Highlight Investigational Treatments for Lysosomal Storage Disorders
• 3. rujna ·

  Yahoo
  JCR Pharmaceuticals Announces Completion of Clinical Trial Notification Process in Japan for Phase I Study of JR-441 for Mucopolysaccharidosis Type IIIA
• 18. srpnja ·

  Yahoo
  JCR Pharmaceuticals Highlights Innovative Gene Therapy Research at the 7th International Forum of Lysosomal Disorders
• 2. srpnja ·

  Yahoo
  MEDIPAL and JCR Announce Completion of Clinical Trial Notification Process in Japan for Phase I/II Study of JR-446 for Mucopolysaccharidosis Type IIIB
• 19. ožujka ·

  Yahoo
  JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with Alexion
• 29. veljače ·

  Yahoo
  JCR Pharmaceuticals Celebrates Rare Disease Day 2024 and Highlights Its Commitment to the Rare Disease Community
• 14. veljače ·

  Yahoo
  JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2024 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders
• 25. siječnja ·

  Yahoo
  JCR Pharmaceuticals to Present at the 20th Annual WORLDSymposium™ 2024
• 21. prosinca ·

  Yahoo
  JCR Pharmaceuticals and Takeda Pharmaceuticals Announce Discontinuation of Gene Therapy Collaboration
• 21. prosinca ·

  Yahoo
  JCR Announces Research Collaboration, Option and License Agreement with Alexion on Discovery of Oligonucleotide Therapeutics Using J-Brain Cargo® Technology